Exhibit 24.1
POWER OF ATTORNEY
Reference is hereby made to the proposed registration by Sanofi under the U.S. Securities Act of 1933, as amended, of debt securities to be issued, from time to time, by Sanofi (the “Debt Securities”). Such Debt Securities will be registered on a registration statement on Form F-3 (the “Registration Statement”) and filed with the U.S. Securities and Exchange Commission (the “SEC”).
KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below hereby constitutes and appoints each of Christopher Viehbacher, Jérôme Contamine and Karen Linehan as such person’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign the Registration Statement and any and all amendments and post-effective amendments thereto and to file the same, with exhibits thereto and any and all other documents that may be required in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or any substitutes therefore, may lawfully do or cause to be done by virtue hereof.
This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original, but which taken together, shall constitute one instrument.
[Remainder of page intentionally left blank]
Date | | Signature | | Title |
| | | | |
| | /s/ Serge Weinberg | | |
March 5, 2013 | | Serge Weinberg | | Chairman of the Board of Directors |
| | | | |
| | /s/ Christopher Viehbacher | | |
March 5, 2013 | | Christopher Viehbacher | | Chief Executive Officer (principal
executive officer) and Director |
| | | | |
| | /s/ Jérôme Contamine | | |
March 5, 2013 | | Jérôme Contamine | | Executive Vice President,
Chief Financial Officer
(principal financial officer) |
| | | | |
| | /s/ Laurent Gilhodes | | |
March 5, 2013 | | Laurent Gilhodes | | Vice President, Group Accounting
and Asset Valuation
(principal accounting officer) |
| | | | |
| | /s/ Laurent Attal | | |
March 5, 2013 | | Laurent Attal | | Director |
| | | | |
| | | | |
, 2013 | | Uwe Bicker | | Director |
| | | | |
| | /s/ Robert Castaigne | | |
March 5, 2013 | | Robert Castaigne | | Director |
| | | | |
| | /s/ Thierry Desmarest | | |
March 5, 2013 | | Thierry Desmarest | | Director |
| | | | |
| | /s/ Lord Douro | | |
March 5, 2013 | | Lord Douro | | Director |
| | | | |
| | /s/ Jean-René Fourtou | | |
March 5, 2013 | | Jean-René Fourtou | | Director |
| | | | |
| | /s/ Claudie Haigneré | | |
March 5, 2013 | | Claudie Haigneré | | Director |
| | | | |
| | | | |
, 2013 | | Igor Landau | | Director |
| | | | |
| | /s/ Suet-Fern Lee | | |
March 5, 2013 | | Suet-Fern Lee | | Director |
| | | | |
| | /s/ Christian Mulliez | | |
March 5, 2013 | | Christian Mulliez | | Director |
| | | | |
| | /s/ Carole Piwnica | | |
March 5, 2013 | | Carole Piwnica | | Director |
2
| | | | |
| | /s/ Klaus Pohle | | |
March 5, 2013 | | Klaus Pohle | | Director |
| | | | |
| | /s/ Gérard Van Kemmel | | |
March 5, 2013 | | Gérard Van Kemmel | | Director |
| | | | |
| | /s/ Gregory Irace | | |
February 22, 2013 | | Gregory Irace | | Authorized Representative
in the United States |
3
